Abstract:Even before Medawar and colleagues published their seminal description of long-term skin transplant survival in mice in the early 1950s, the field of transplantation was fascinated by the concept of tolerance. Following this pioneering work, many thought that clinical tolerance was just around the corner. However, the first report of clinical tolerance was not published until 1975. It took another 10-20 years before advances in immunology suggested approaches that could be exploited to induce tolerance in humans. These advances included protocols in rodents that induced a state of mixed hematopoietic chimerism and subsequent tolerance to transplanted organs and the description of T cells with suppressive or regulatory properties. In this issue of HEPATOLOGY, Todo et al. report 10 patients undergoing living donor liver transplantation who received an infusion of an ex vivo-generated cell product enriched for regulatory cells with the aim of inducing tolerance. Tapering of immunosuppression began at 6 months, with complete withdrawal achieved by 18 months. This was successful in 7 of the 10 patients, with the three failures occurring in individuals with autoimmune liver diseases. At the time of this report, the duration of tolerance ranged from 16 to 33 months. Importantly, the cell infusion was not associated with any adverse events, and all treated patients—including the 3 who failed weaning of immunosuppressive drugs—have normal graft function without histologic evidence of injury. So why is the Todo et al. study significant? Despite over two decades of work aimed at characterizing regulatory cells, determining how they mediate their suppressive effects, and developing protocols to expand them, this study is the first to demonstrate that they can be exploited to induce tolerance after organ transplantation. This is also the first study to intentionally induce tolerance in patients undergoing liver transplantation. How does this work compare with and advance previous studies of tolerance in liver transplant recipients? Previous studies have capitalized on the relatively high incidence of spontaneous tolerance after liver transplantation to permit the gradual withdrawal of immunosuppression in liver transplant recipients initially treated with conventional immunosuppressive regimens. These studies have found that the success of weaning recipients from immunosuppressive drugs was strongly correlated with increasing time since transplantation. The advantage of the approach described by Todo et al. is that it allows for earlier withdrawal of the drugs, thereby saving patients years of the morbidities associated with immunosuppression. Several groups have reported strategies that induce tolerance to transplanted kidneys with significant success. Each of these protocols use the infusion of various populations of donor cells in the setting of recipient conditioning consisting of irradiation and nonmyeloablative chemotherapeutic agents to induce variable states of chimerism. It remains to be determined whether these differences between the strategies for inducing tolerance following liver and kidney transplantation reflect fundamental organ-specific differences in the mechanisms responsible for the development and maintenance of tolerance or are artifacts related to differences in the patient populations studied, study design, and the choices of the relatively small number of investigative teams. However, should regulatoryAbbreviations: Treg, regulatory T cell.

Differentiated Knowledge Distillation: Patient-specific Single-Sample Personalization for Electrocardiogram Diagnostic Models

High-Performance Personalized Heartbeat Classification Model for Long-Term ECG Signal

ECG Authentication Method Based on Parallel Multi-Scale One-Dimensional Residual Network with Center and Margin Loss.

Deep Learning for Personalized Electrocardiogram Diagnosis: A Review

A Deep Knowledge Distillation framework for EEG assisted enhancement of single-lead ECG based sleep staging

Personalized Heart Disease Detection via ECG Digital Twin Generation

Transplantation tolerance: Coming of age

MVKT-ECG: Efficient Single-lead ECG Classification on Multi-Label Arrhythmia by Multi-View Knowledge Transferring

MVKT-ECG: Efficient single-lead ECG classification for multi-label arrhythmia by multi-view knowledge transferring

EEG aided boosting of single-lead ECG based sleep staging with Deep Knowledge Distillation

Teacher Assistant-Based Knowledge Distillation Extracting Multi-level Features on Single Channel Sleep EEG

Vector quantization based Gaussian modeling for speaker verification

Knowledge-shot Learning: an Interpretable Deep Model for Classifying Imbalanced Electrocardiography Data

Evaluation-oriented Knowledge Distillation for Deep Face Recognition

Interpretable Deep Learning for Automatic Diagnosis of 12-lead Electrocardiogram

Knowledge-Distilled Graph Neural Networks for Personalized Epileptic Seizure Detection

DSP-KD: Dual-Stage Progressive Knowledge Distillation for Skin Disease Classification

CardioLearn: A Cloud Deep Learning Service for Cardiac Disease Detection from Electrocardiogram

Improving generalization performance of electrocardiogram classification models

Practical intelligent diagnostic algorithm for wearable 12-lead ECG via self-supervised learning on large-scale dataset

Enhancing Low-Density EEG-Based Brain-Computer Interfaces with Similarity-Keeping Knowledge Distillation